Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?
Yahoo Finance · 2 weeks ago
Open | 11.37 |
High | 11.44 |
Low | 11.23 |
Mkt Cap | 291.11M |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 11.32 |
52 Wk. Low | 3.84 |
52 Wk. High | 14.75 |
Related stocks
American biotechnology company
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. Wikipedia
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | - | - |
Net Income | -30.47M | - |
Diluted EPS | -1.31 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$1.10 | - |
Q1 2024 | -$1.00 | -$1.31 |
Q4 2023 | -$1.27 | -$1.12 |
S&P 500^GSPC | 5,484.15+25.05 (+0.46%) |
Dow 30^DJI | 40,617.93+28.59 (+0.07%) |
Nasdaq^IXIC | 17,508.86+150.98 (+0.87%) |
259.51+2.98% | |
78.99+3.21% | |
100.79-4.23% |